nach oben

Cardiovascular Toxicology

Erschienen in:

06.05.2022 | Nuclear Medicine

Investigating Radioprotective Effect of Hesperidin/Diosmin Compound Against ^99mTc-MIBI-Induced Cardiotoxicity: Animal Study

verfasst von: Fereshteh Koosha, Peyman Sheikhzadeh

Erschienen in: Cardiovascular Toxicology | Ausgabe 7/2022

Einloggen, um Zugang zu erhalten

Abstract

This study was designed to indicate the cardiotoxicity due to ^99mTc-MIBI injection in myocardial perfusion imaging in wistar Rats. In addition, protective effect of hesperidin/diosmin compound (HDC) against the cardiotoxicity was evaluated. Twenty five male rats were randomly divided into five groups. The rats in Group 1 (control) only received PBS. For Group 2 (HDC only) the rats treated with only HDC. The rats in Group 3 (radiation) received PBS before injection and exposure to 1 mCi ^99mTc-MIBI. The rats in Group 4 (HDC + radiation) treated with HDC before exposure. For Group 5 (radiation + HDC) the rats were exposed and thereafter administered HDC. The Animals of this study were orally administered 100 mg/kg/day of the HDC for 7 days. Then, the rats were sacrificed and afterwards their heart tissues were carefully extracted for biochemical and histopathological evaluations. According to our results in the radiation group, the rate of rupture of cardiomyocyte fibers was higher than other groups, and in some fibers, the presence of lymphocytes was observed. Relative improvement was observed in radiation + HDC group compared to the radiation group and also a small number of cardiomyocyte fibers were torn and in some fibers, the presence of lymphocytes was observed, which was less than the model group. Collagen deposition significantly increased in radiation group compared to control group (P < 0.05). It can be seen that the percentage of collagen deposition decreased substantially in the group treated with HDC before or after radiation compared to radiation group (P < 0.05). The MDA activities significantly reduced (P < 0.05) in both (HDC + radiation) and (radiation + HDC) groups. SOD activity significantly increased in both (radiation + HDC) and (HDC + radiation) groups compared to that of radiation group (P < 0.05). It could be concluded that the HDC is safe and promising useful therapeutic agent in radiation induced cardiotoxicity for patients undergoing nuclear medicine procedures.

Graphical Abstract

Yusuf, S. W., Venkatesulu, B. P., Mahadevan, L. S., & Krishnan, S. (2017). Radiation-induced cardiovascular disease: A clinical perspective. Frontiers in Cardiovascular Medicine, 4, 66. https://doi.org/10.3389/fcvm.2017.00066CrossRefPubMedPubMedCentral

Chen, J., Einstein, A. J., Fazel, R., Krumholz, H. M., Wang, Y., Ross, J. S., Ting, H. H., Shah, N. D., Nasir, K., & Nallamothu, B. K. (2010). Cumulative exposure to ionizing radiation from diagnostic and therapeutic cardiac imaging procedures: A population-based analysis. Journal of the American College of Cardiology, 56(9), 702–711. https://doi.org/10.1016/j.jacc.2010.05.014CrossRefPubMedPubMedCentral

Darby, S. C., Cutter, D. J., Boerma, M., Constine, L. S., Fajardo, L. F., Kodama, K., Mabuchi, K., Marks, L. B., Mettler, F. A., & Pierce, L. J. (2010). Radiation-related heart disease: Current knowledge and future prospects. International Journal of Radiation Oncology Biology, 76(3), 656–665. https://doi.org/10.1016/j.ijrobp.2009.09.064CrossRef

Group EBCTC. (2005). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. The Lancet, 366(9503), 2087–2106. https://doi.org/10.1016/S0140-6736(05)67887-7CrossRef

Boice, J. D., Jr. (2007). An affair of the heart. Journal of the National Cancer Institute., 99(3), 186–187. https://doi.org/10.1093/jnci/djk058CrossRefPubMed

Shimizu, Y., Kodama, K., Nishi, N., Kasagi, F., Suyama, A., Soda, M., Grant, E. J., Sugiyama, H., Sakata, R., & Moriwaki, H. (2010). Radiation exposure and circulatory disease risk: Hiroshima and Nagasaki atomic bomb survivor data, 1950–2003. BMJ. https://doi.org/10.1136/bmj.b5349CrossRefPubMedPubMedCentral

Shimizu, Y., Kato, H., Schull, W. J., & Hoel, D. G. (1992). Studies of the mortality of A-bomb survivors. 9. Mortality, 1950–1985: Part 3. Noncancer mortality based on the revised doses (DS86). Radiation Research, 130(2), 249–266.CrossRef

Wang, H., Wei, J., Zheng, Q., Meng, L., Xin, Y., Yin, X., & Jiang, X. (2019). Radiation-induced heart disease: A review of classification, mechanism and prevention. International Journal of Biological Sciences, 15(10), 2128. https://doi.org/10.7150/ijbs.35460CrossRefPubMedPubMedCentral

Salata, C., Ferreira-Machado, S. C., De Andrade, C. B. V., Mencalha, A. L., Mandarim-De-Lacerda, C. A., & de Almeida, C. E. (2014). Apoptosis induction of cardiomyocytes and subsequent fibrosis after irradiation and neoadjuvant chemotherapy. International Journal of Radiation Biology, 90(4), 284–290. https://doi.org/10.3109/09553002.2014.887869CrossRefPubMed

10.

Sridharan, V., Aykin-Burns, N., Tripathi, P., Krager, K. J., Sharma, S. K., Moros, E. G., Corry, P. M., Nowak, G., Hauer-Jensen, M., & Boerma, M. (2014). Radiation-induced alterations in mitochondria of the rat heart. Radiation Research, 181(3), 324–334. https://doi.org/10.1667/RR13452.1CrossRefPubMedPubMedCentral

11.

Citrin, D., Cotrim, A. P., Hyodo, F., Baum, B. J., Krishna, M. C., & Mitchell, J. B. (2010). Radioprotectors and mitigators of radiation-induced normal tissue injury. The Oncologist, 15(4), 360. https://doi.org/10.1634/theoncologist.2009-S104CrossRefPubMedPubMedCentral

12.

Hosseinimehr, S. J. (2007). Trends in the development of radioprotective agents. Drug Discovery Today, 12(19–20), 794–805. https://doi.org/10.1016/j.drudis.2007.07.017CrossRefPubMed

13.

Khezerloo, D., Mortezazadeh, T., Farhood, B., Sheikhzadeh, P., Seyfizadeh, N., & Pezhman, L. (2019). The effect of date palm seed extract as a new potential radioprotector in gamma-irradiated mice. Journal of Cancer Research and Therapeutics, 15(3), 517–521. https://doi.org/10.4103/jcrt.JCRT_1341_16CrossRefPubMed

14.

Zhang, Q.-Y., Wang, F.-X., Jia, K.-K., & Kong, L.-D. (2018). Natural product interventions for chemotherapy and radiotherapy-induced side effects. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2018.01253CrossRefPubMedPubMedCentral

15.

Tejada, S., Pinya, S., Martorell, M., Capó, X., Tur, J. A., Pons, A., & Sureda, A. (2018). Potential anti-inflammatory effects of hesperidin from the genus citrus. Current Medicinal Chemistry, 25(37), 4929–4945. https://doi.org/10.2174/0929867324666170718104412CrossRefPubMed

16.

Kilic, K., Sakat, M. S., Yildirim, S., Kandemir, F. M., Gozeler, M. S., Dortbudak, M. B., & Kucukler, S. (2019). The amendatory effect of hesperidin and thymol in allergic rhinitis: An ovalbumin-induced rat model. European Archives of Oto-Rhino-Laryngology, 276(2), 407–415. https://doi.org/10.1007/s00405-018-5222-yCrossRefPubMed

17.

Cho, J. (2006). Antioxidant and neuroprotective effects of hesperidin and its aglycone hesperetin. Archives of Pharmacal Research, 29(8), 699–706. https://doi.org/10.1007/BF02968255CrossRefPubMed

18.

Roohbakhsh, A., Parhiz, H., Soltani, F., Rezaee, R., & Iranshahi, M. (2015). Molecular mechanisms behind the biological effects of hesperidin and hesperetin for the prevention of cancer and cardiovascular diseases. Life Sciences, 124, 64–74. https://doi.org/10.1016/j.lfs.2014.12.030CrossRefPubMed

19.

Garg, A., Garg, S., Zaneveld, L., & Singla, A. (2001). Chemistry and pharmacology of the citrus bioflavonoid hesperidin. Phytotherapy Research, 15(8), 655–669. https://doi.org/10.1002/ptr.1074CrossRefPubMed

20.

Rezaeyan, A., Haddadi, G. H., Hosseinzadeh, M., Moradi, M., & Najafi, M. (2016). Radioprotective effects of hesperidin on oxidative damages and histopathological changes induced by X-irradiation in rats heart tissue. Journal of Medical Physics/Association of Medical Physicists of India, 41(3), 182. https://doi.org/10.4103/0971-6203.189482CrossRefPubMedCentral

21.

Srinivasan, S., & Pari, L. (2012). Ameliorative effect of diosmin, a citrus flavonoid against streptozotocin-nicotinamide generated oxidative stress induced diabetic rats. Chemico-Biological Interactions, 195(1), 43–51. https://doi.org/10.1016/j.cbi.2011.10.003CrossRefPubMed

22.

Kastrup, J., Petersen, P., Dejgård, A., Angelo, H. R., & Hilsted, J. (1987). Intravenous lidocaine infusion—a new treatment of chronic painful diabetic neuropathy? Pain, 28(1), 69–75. https://doi.org/10.1016/0304-3959(87)91061-XCrossRefPubMed

23.

Tanrikulu, Y., Şahin, M., Kismet, K., Kilicoglu, S. S., Devrim, E., Tanrikulu, C. S., Erdemli, E., Erel, S., Bayraktar, K., & Akkus, M. A. (2013). The protective effect of diosmin on hepatic ischemia reperfusion injury: an experimental study. Bosnian Journal of Basic Medical Sciences, 13(4), 218. https://doi.org/10.17305/bjbms.2013.2305CrossRefPubMedPubMedCentral

24.

Imam, F., Al-Harbi, N. O., Al-Harbi, M. M., Ansari, M. A., Zoheir, K. M., Iqbal, M., Anwer, M. K., Al Hoshani, A. R., Attia, S. M., & Ahmad, S. F. (2015). Diosmin downregulates the expression of T cell receptors, pro-inflammatory cytokines and NF-κB activation against LPS-induced acute lung injury in mice. Pharmacological Research, 102, 1–11. https://doi.org/10.1016/j.phrs.2015.09.001CrossRefPubMed

25.

Mahgoub, S., Sallam, A. O., Sarhan, H. K., Ammar, A. A., & Soror, S. H. (2020). Role of Diosmin in protection against the oxidative stress induced damage by gamma-radiation in Wistar albino rats. Regulatory Toxicology and Pharmacology, 113, 104622. https://doi.org/10.1016/j.yrtph.2020.104622CrossRefPubMed

26.

Sezer, A., Usta, U., Kocak, Z., & Yagci, M. A. (2011). The effect of a flavonoid fractions diosmin+ hesperidin on radiation-induced acute proctitis in a rat model. Journal of Cancer Research and Therapeutics, 7(2), 152. https://doi.org/10.4103/0973-1482.8292CrossRefPubMed

27.

Abdel-Rafei, M., Amin, M., & Hasan, H. (2017). Novel effect of Daflon and low-dose γ-radiation in modulation of thioacetamide-induced hepatic encephalopathy in male albino rats. Human & Experimental Toxicology, 36(1), 62–81. https://doi.org/10.1177/0960327116637657CrossRef

28.

Dreyfuss, A. D., Goia, D., Shoniyozov, K., Shewale, S. V., Velalopoulou, A., Mazzoni, S., Avgousti, H., Metzler, S. D., Bravo, P. E., & Feigenberg, S. J. (2021). A novel mouse model of radiation-induced cardiac injury reveals biological and radiological biomarkers of cardiac dysfunction with potential clinical relevance. Clinical Cancer Research, 27(8), 2266–2276. https://doi.org/10.1158/1078-0432.CCR-20-3882CrossRefPubMed

29.

Cicone, F., Viertl, D., Quintela Pousa, A. M., Denoël, T., Gnesin, S., Scopinaro, F., Vozenin, M.-C., & Prior, J. O. (2017). Cardiac radionuclide imaging in rodents: A review of methods, results, and factors at play. Frontiers in Medicine, 4, 35. https://doi.org/10.3389/fmed.2017.00035CrossRefPubMedPubMedCentral

30.

Fooladi, M., Cheki, M., Shirazi, A., Sheikhzadeh, P., Amirrashedi, M., Ghahramani, F. and Khoobi, M. (2021). Histopathological evaluation of protective effect of telmisartan against radiation-induced bone marrow injury. Journal of Biomedical Physics and Engineering. Retrieved from https://jbpe.sums.ac.ir/article_47577.html

31.

Leary, S., Underwood, W., Anthony, R., Cartner, S., Corey, D., Grandin, T., Greenacre, C., Gwaltney-Brant, S., McCrackin, M. A., Meyer, R., Miller, D., Shearer, J., & Yanong, R. (2013). AVMA guidelines for the euthanasia of animals: 2013 edition. American Veterinary Medical Association.

32.

Mathers, C. D., & Loncar, D. (2006). Projections of global mortality and burden of disease from 2002 to 2030. PLoS Medicine, 3(11), e442. https://doi.org/10.1371/journal.pmed.0030442CrossRefPubMedPubMedCentral

33.

Hosseinimehr, S. J. (2009). Potential utility of radioprotective agents in the practice of nuclear medicine. Cancer Biotherapy and Radiopharmaceuticals, 24(6), 723–731. https://doi.org/10.1089/cbr.2009.0635CrossRefPubMed

34.

Taibi, N., Aka, P., Kirsch-Volders, M., Bourgeois, P., Frühling, J., & Szpireer, C. (2006). Radiobiological effect of 99mTechnetium-MIBI in human peripheral blood lymphocytes: Ex vivo study using micronucleus/FISH assay. Cancer Letters, 233(1), 68–78. https://doi.org/10.1016/j.canlet.2005.02.032CrossRefPubMed

35.

Merz, T., Tatum, J., & Hirsch, J. (1986). Technetium-99m-labeled lymphocytes: A radiotoxicity study. Journal of Nuclear Medicine, 27(1), 105–110.PubMed

36.

Yahyapour, R., Amini, P., Rezapoor, S., Rezaeyan, A., Farhood, B., Cheki, M., Fallah, H., & Najafi, M. (2018). Targeting of inflammation for radiation protection and mitigation. Current Molecular Pharmacology, 11(3), 203–210. https://doi.org/10.2174/1874467210666171108165641CrossRefPubMed

37.

Hosseinimehr, S., & Nemati, A. (2006). Radioprotective effects of hesperidin against gamma irradiation in mouse bone marrow cells. The British Journal of Radiology, 79(941), 415–418. https://doi.org/10.1259/bjr/40692384CrossRefPubMed

38.

Hosseinimehr, S. J., Ahmadi, A., Beiki, D., Habibi, E., & Mahmoudzadeh, A. (2009). Protective effects of hesperidin against genotoxicity induced by 99mTc-MIBI in human cultured lymphocyte cells. Nuclear Medicine and Biology, 36(7), 863–867. https://doi.org/10.1016/j.nucmedbio.2009.06.002CrossRefPubMed

39.

Di Meo, S., & Venditti, P. (2020). Evolution of the knowledge of free radicals and other oxidants. Oxidative Medicine and Cellular Longevity. https://doi.org/10.1155/2020/9829176CrossRefPubMedPubMedCentral

40.

Pradeep, K., Park, S. H., & Ko, K. C. (2008). Hesperidin a flavanoglycone protects against γ-irradiation induced hepatocellular damage and oxidative stress in Sprague-Dawley rats. European Journal of Pharmacology, 587(1–3), 273–280. https://doi.org/10.1016/j.ejphar.2008.03.052CrossRefPubMed

Titel: Investigating Radioprotective Effect of Hesperidin/Diosmin Compound Against 99mTc-MIBI-Induced Cardiotoxicity: Animal Study
verfasst von: Fereshteh Koosha
Peyman Sheikhzadeh
Publikationsdatum: 06.05.2022
Verlag: Springer US
Schlagwörter: Nuclear Medicine
Collagen
Erschienen in: Cardiovascular Toxicology / Ausgabe 7/2022
Print ISSN: 1530-7905
Elektronische ISSN: 1559-0259
DOI: https://doi.org/10.1007/s12012-022-09744-8

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Investigating Radioprotective Effect of Hesperidin/Diosmin Compound Against ^99mTc-MIBI-Induced Cardiotoxicity: Animal Study

Abstract

Graphical Abstract

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Graphical Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2022

Protective Effect of Curcumin, Chrysin and Thymoquinone Injection on Trastuzumab-Induced Cardiotoxicity via Mitochondrial Protection

The Cardiotoxic Effect of Roundup® is not Induced by Glyphosate: A Non-specific Blockade of Human CaV1.2 Channels

Mesenchymal Stem Cell-Derived Exosome-Loaded microRNA-129-5p Inhibits TRAF3 Expression to Alleviate Apoptosis and Oxidative Stress in Heart Failure

Evaluating the Role of lncRNAs in the Incidence of Cardiovascular Diseases in Androgenetic Alopecia Patients

microRNA miR-133a as a Biomarker for Doxorubicin-Induced Cardiotoxicity in Women with Breast Cancer: A Signaling Pathway Investigation

Association Between Serum Selenium Concentration and OPG/RANKL/RANK Axis in Patients with Arterial Hypertension